ALNYLAM PHARMACEUTICALS, INC. Quarterly Debt-to-equity in % from Q1 2011 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Alnylam Pharmaceuticals, Inc. quarterly Debt-to-equity history and growth rate from Q1 2011 to Q3 2024.
  • Alnylam Pharmaceuticals, Inc. Debt-to-equity for the quarter ending September 30, 2024 was -3.96K %, a 159% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 -3.96K -2.43K -159% Sep 30, 2024
Q2 2024 -2.65K -993 -60% Jun 30, 2024
Q1 2024 -1.57K +3K +65.6% Mar 31, 2024
Q4 2023 -1.47K -5.31K -138% Dec 31, 2023
Q3 2023 -1.53K -2.7K -231% Sep 30, 2023
Q2 2023 -1.65K -2.28K -366% Jun 30, 2023
Q1 2023 -4.57K -5.01K -1135% Mar 31, 2023
Q4 2022 3.84K +3.5K +1015% Dec 31, 2022
Q3 2022 1.17K +886 +312% Sep 30, 2022
Q2 2022 622 +386 +164% Jun 30, 2022
Q1 2022 441 +248 +129% Mar 31, 2022
Q4 2021 344 +196 +132% Dec 31, 2021
Q3 2021 284 +174 +158% Sep 30, 2021
Q2 2021 236 +153 +185% Jun 30, 2021
Q1 2021 193 +131 +214% Mar 31, 2021
Q4 2020 148 +96.1 +184% Dec 31, 2020
Q3 2020 110 +67.8 +160% Sep 30, 2020
Q2 2020 82.8 +51.6 +165% Jun 30, 2020
Q1 2020 61.4 +42.8 +230% Mar 31, 2020
Q4 2019 52.2 +39.1 +298% Dec 31, 2019
Q3 2019 42.4 +30.9 +268% Sep 30, 2019
Q2 2019 31.2 +17.2 +124% Jun 30, 2019
Q1 2019 18.6 +0.93 +5.27% Mar 31, 2019
Q4 2018 13.1 -10.8 -45.1% Dec 31, 2018
Q3 2018 11.5 -20.4 -63.9% Sep 30, 2018
Q2 2018 13.9 -18.3 -56.8% Jun 30, 2018
Q1 2018 17.7 -14.1 -44.4% Mar 31, 2018
Q4 2017 23.9 -1.02 -4.09% Dec 31, 2017
Q3 2017 32 +13.7 +75.5% Sep 30, 2017
Q2 2017 32.3 +19 +143% Jun 30, 2017
Q1 2017 31.8 +22.4 +238% Mar 31, 2017
Q4 2016 24.9 +16 +179% Dec 31, 2016
Q3 2016 18.2 +8.28 +83.4% Sep 30, 2016
Q2 2016 13.3 +3.19 +31.6% Jun 30, 2016
Q1 2016 9.38 -1.08 -10.3% Mar 31, 2016
Q4 2015 8.94 -2.86 -24.2% Dec 31, 2015
Q3 2015 9.92 -4.65 -31.9% Sep 30, 2015
Q2 2015 10.1 -10.8 -51.7% Jun 30, 2015
Q1 2015 10.5 -21.2 -67% Mar 31, 2015
Q4 2014 11.8 -40 -77.2% Dec 31, 2014
Q3 2014 14.6 -44.2 -75.2% Sep 30, 2014
Q2 2014 20.9 -44.9 -68.2% Jun 30, 2014
Q1 2014 31.7 -40.9 -56.4% Mar 31, 2014
Q4 2013 51.7 -30.3 -36.9% Dec 31, 2013
Q3 2013 58.8 -26.8 -31.3% Sep 30, 2013
Q2 2013 65.9 -32.2 -32.9% Jun 30, 2013
Q1 2013 72.6 -47 -39.3% Mar 31, 2013
Q4 2012 82.1 -64.6 -44% Dec 31, 2012
Q3 2012 85.5 -63.2 -42.5% Sep 30, 2012
Q2 2012 98.1 -54.1 -35.6% Jun 30, 2012
Q1 2012 120 -36.8 -23.5% Mar 31, 2012
Q4 2011 147 Dec 31, 2011
Q3 2011 149 Sep 30, 2011
Q2 2011 152 Jun 30, 2011
Q1 2011 156 Mar 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.